Morphological brain changes associated with negative symptoms in patients with 22q11.2 Deletion Syndrome

被引:9
|
作者
Mihailov, Angeline [1 ]
Padula, Maria Carmela [1 ]
Scariati, Elisa [1 ]
Schaer, Marie [1 ]
Schneider, Maude [1 ,2 ]
Eliez, Stephan [1 ,3 ]
机构
[1] Univ Geneva, Dept Psychiat, Dev Imaging & Psychopathol Lab, Rue David Dufour,1,Case Postal 50, CH-1211 Geneva 8, Switzerland
[2] Katholieke Univ Leuven, Dept Neurosci, Ctr Contextual Psychiat, Leuven, Belgium
[3] Univ Geneva, Sch Med, Dept Genet Med & Dev, Geneva, Switzerland
基金
瑞士国家科学基金会;
关键词
Schizophrenia; Psychotic symptoms; Cluster analysis; Gyrification; FreeSurfer; FUSIFORM FACE AREA; PSYCHOTIC SYMPTOMS; LONGITUDINAL DEVELOPMENT; CORTICAL GYRIFICATION; POSITIVE SYMPTOMS; HIGH-RISK; SCHIZOPHRENIA; THICKNESS; BIRTH; ADOLESCENTS;
D O I
10.1016/j.schres.2017.01.031
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Approximately 30% of individuals with 22q11.2 Deletion Syndrome (22q11DS) develop schizophrenia during adolescence/early adulthood, making this syndrome a model for the disorder. Furthermore, negative symptoms exist in up to 80% of patients diagnosed with 22q11DS. The present study aims to uncover morphological brain alterations associated with negative symptoms in a cohort of patients with 22q11DS who are at-risk for developing schizophrenia. A total of 71 patients with 22q11DS aged 12 to 35 (54% females) with no past or present diagnosis of a schizophrenia were included in the study. Psychotic symptom scores were used to divide patients into subgroups by means of a cluster analysis. Three major subgroups were evident: patients with low negative and positive symptoms; patients with high negative symptoms and low positive symptoms; and patients with high negative and positive symptoms. Cortical volume, thickness and gyrification were compared between subgroups using FreeSurfer software. Results showed that patients with high negative symptoms, compared to those with low negative symptoms, have decreased gyrification in the medial occipito-temporal (MOT) and lateral temporo-parietal (LTP) cortices of the left hemisphere, and in the medial temporal (MT)/posterior cingulate (PCC) cortices of the right hemisphere. These findings suggest that high negative symptoms are associated with gyrification reductions predominantly in medial occipital and temporal regions, which are areas implicated in social cognition and early visual processing. Furthermore, as cortical folding develops in utero and during the first years of life, reduced gyrification may represent an early biomarker predicting the development of negative symptoms. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:52 / 58
页数:7
相关论文
共 50 条
  • [31] Heterotopia in Individuals with 22q11.2 Deletion Syndrome
    Neuhaus, E.
    Hattingen, E.
    Breuer, S.
    Steidl, E.
    Polomac, N.
    Rosenow, F.
    Rueber, T.
    Herrmann, E.
    Ecker, C.
    Kushan, L.
    Lin, A.
    Vajdi, A.
    Bearden, C. E.
    Jurcoane, A.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2021, 42 (11) : 2070 - 2076
  • [32] Obesity in adults with 22q11.2 deletion syndrome
    Voll, Sarah L.
    Boot, Erik
    Butcher, Nancy J.
    Cooper, Samantha
    Heung, Tracy
    Chow, Eva W. C.
    Silversides, Candice K.
    Bassett, Anne S.
    GENETICS IN MEDICINE, 2017, 19 (02) : 204 - 208
  • [33] Pediatric healthcare costs for patients with 22q11.2 deletion syndrome
    Benn, Peter
    Iyengar, Sushma
    Crowley, Terrence Blaine
    Zackai, Elaine H.
    Burrows, Evanette K.
    Moshkevich, Solomon
    McDonald-McGinn, Donna M.
    Sullivan, Kathleen E.
    Demko, Zachary
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2017, 5 (06): : 631 - 638
  • [34] Complement Activation in 22q11.2 Deletion Syndrome
    Grinde, Dina
    Overland, Torstein
    Lima, Kari
    Schjalm, Camilla
    Mollnes, Tom Eirik
    Abrahamsen, Tore G.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2020, 40 (03) : 515 - 523
  • [35] Practical Guidelines for Managing Patients with 22q11.2 Deletion Syndrome
    Bassett, Anne S.
    McDonald-McGinn, Donna M.
    Devriendt, Koen
    Digilio, Maria Cristina
    Goldenberg, Paula
    Habel, Alex
    Marino, Bruno
    Oskarsdottir, Solveig
    Philip, Nicole
    Sullivan, Kathleen
    Swillen, Ann
    Vorstman, Jacob
    JOURNAL OF PEDIATRICS, 2011, 159 (02) : 332 - U213
  • [36] Disrupted fornix integrity in children with chromosome 22q11.2 deletion syndrome
    Deng, Yi
    Goodrich-Hunsaker, Naomi J.
    Cabaral, Margarita
    Amaral, David G.
    Buonocore, Michael H.
    Harvey, Danielle
    Kalish, Kristopher
    Carmichael, Owen T.
    Schumann, Cynthia M.
    Lee, Aaron
    Dougherty, Robert F.
    Perry, Lee M.
    Wandell, Brian A.
    Simon, Tony J.
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2015, 232 (01) : 106 - 114
  • [37] Synaptic-dependent developmental dysconnectivity in 22q11.2 deletion syndrome
    Alvino, Filomena Grazia
    Gini, Silvia
    Minetti, Antea
    Pagani, Marco
    Sastre-Yaguee, David
    Barsotti, Noemi
    De Guzman, Elizabeth
    Schleifer, Charles
    Stuefer, Alexia
    Kushan, Leila
    Montani, Caterina
    Galbusera, Alberto
    Papaleo, Francesco
    Kates, Wendy R.
    Murphy, Declan
    Lombardo, Michael Vincent
    Pasqualetti, Massimo
    Bearden, Carrie E.
    Gozzi, Alessandro
    SCIENCE ADVANCES, 2025, 11 (11):
  • [38] Altered cortical thickness development in 22q11.2 deletion syndrome and association with psychotic symptoms
    Bagautdinova, Joelle
    Zoller, Daniela
    Schaer, Marie
    Padula, Maria Carmela
    Mancini, Valentina
    Schneider, Maude
    Eliez, Stephan
    MOLECULAR PSYCHIATRY, 2021, 26 (12) : 7671 - 7678
  • [39] Neurobiological perspective of 22q11.2 deletion syndrome
    Zinkstok, Janneke R.
    Boot, Erik
    Bassett, Anne S.
    Hiroi, Noboru
    Butcher, Nancy J.
    Vingerhoets, Claudia
    Vorstman, Jacob A. S.
    van Amelsvoort, Therese A. M. J.
    LANCET PSYCHIATRY, 2019, 6 (11): : 951 - 960
  • [40] Schizotypal traits in adolescents with 22q11.2 deletion syndrome: validity, reliability and risk for psychosis
    Fonseca-Pedrero, E.
    Debbane, M.
    Schneider, M.
    Badoud, D.
    Eliez, S.
    PSYCHOLOGICAL MEDICINE, 2016, 46 (05) : 1005 - 1013